Dear valued partners and colleagues,
Welcome to the latest edition of the ICARS newsletter.
This is a period of growth and transition for ICARS. As we prepare to launch our new Strategy 2026-2030, we are also pleased to welcome Helle Engslund Krarup as our new Executive Director, marking the beginning of an exciting new chapter for the organisation.
In this issue, you will find highlights from recent global engagements and partnerships, updates from across our project portfolio, and an introduction to seven newly approved initiatives addressing antimicrobial resistance across the One Health spectrum. We also share new publications, resources, and insights from our work with partners around the world.
Behind every update is a shared commitment to developing practical, context-specific solutions that help countries translate evidence into action. We are grateful to all our partners, funders, project teams, and collaborators who make this work possible.
We hope you enjoy this update and invite you to follow us on LinkedIn for the latest news, publications, and upcoming events. If you know colleagues who may be interested in ICARS' work, please feel free to share this newsletter and encourage them to subscribe.
With warm regards,
The ICARS Team

Join ICARS for the launch of our new Strategy 2026-2030, outlining how we have refined our approach and will continue working with partners to advance sustainable impact through implementation research and country-led action.
Building on five years of partnership-driven efforts across low- and middle-income countries, the webinar will introduce the strategic priorities guiding ICARS’ work through 2030 and explore what this means for project teams, partners, funders and future collaboration on AMR mitigation. The session will include reflections on lessons learned, country ownership, translating evidence into practice, and sustaining impact in a changing global health environment.

ICARS is pleased to announce the appointment of Helle Engslund Krarup as its new Executive Director. Helle has served as Director of Operations since May 2020 and brings to the role deep knowledge of the organisation, a clear commitment to ICARS’ mission and continued impact in addressing antimicrobial resistance globally. Her experience spans policy development, cross-government collaboration, and international health engagement, with a consistent focus on translating evidence into practical outcomes.

ICARS participated in the One Health Summit in Lyon, France, represented by Executive Director Helle Engslund Krarup, together with Theresa Høgenhaug and Rodolphe Mader. The Summit convened leaders from governments, international organisations, academia, and the private sector to advance the One Health agenda and address global challenges, including AMR.

In March 2026, an ICARS delegation participated in the 1st Americas Regional Meeting on AMR in Brazil. The event brought together government representatives from 23 countries, international organisations, as well as global partners, researchers, and AMR stakeholders from across the LAC region.

In March, ICARS visited Bogotá and Barranquilla, Colombia, to support the continued implementation and dissemination of two ICARS-supported AMR mitigation projects spanning animal and human health.

In May, ICARS took part in a five-day visit that included the official launch of the neonatal AMR project in Ghana. The project aims to reduce the incidence of neonatal infections, including those caused by drug-resistant pathogens and also improve health outcomes with rational antibiotic use for neonatal infections.

In March 2026, an ICARS delegation travelled to Kampala, Uganda, to participate in the official launch of an ICARS-supported project that will test a practical, evidence-based approach to reducing surgical site infections and improving antibiotic use during surgeries in three Ugandan regional referral hospitals.

In Argentina, a project will use a combination of microbiological and social science research to assess the long-term impact of the 2019 colistin ban on AMR, livestock production practices and stakeholder experiences.
In Bangladesh, a project aims to better understand antimicrobial use and governance in the country’s growing contract poultry sector. Through value chain mapping and policy analysis, the project will identify opportunities to strengthen AMS and support efforts to combat AMR.
The BEACOI-Africa project aims to strengthen capacity for economic evaluation of AMR interventions across multiple sectors. Through training, mentorship, and the development of practical tools the project will support evidence-informed AMR policies and investment decisions.
In Botswana, a project aims to strengthen IPC in hospitals to reduce healthcare-associated infections and AMR. The project will implement and evaluate tailored interventions in neonatal and other high-risk hospital wards.
The One Health Drive AMS-IPC Africa project aims to develop and implement a multidisciplinary capacity-building programme for AMS, IPC, and biosecurity through a structured One Health and quality improvement approach, building on the existing Drive-AMS model.
In Rwanda, a project aims to strengthen AMS for surgical antibiotic prophylaxis to reduce surgical site infections and improve patient outcomes. Through training, monitoring, and feedback, the project will support better adherence to antibiotic guidelines and infection prevention practices.
In Zimbabwe, a project aims to strengthen wastewater management to reduce environmental pollution by antibiotic resistant microbes, antibiotic resistant genes and antibiotic residues in wastewater from poultry abattoirs.






